These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5316313)

  • 41. Pharmacokinetics of ochratoxin A in animals.
    Galtier P
    IARC Sci Publ; 1991; (115):187-200. PubMed ID: 1820333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing interactions of binary mixtures of Penicillium mycotoxins (PMs) by using a bovine macrophage cell line (BoMacs).
    Oh SY; Cedergreen N; Yiannikouris A; Swamy HV; Karrow NA
    Toxicol Appl Pharmacol; 2017 Mar; 318():33-40. PubMed ID: 28130037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Teratogenicity of Ochratoxin A and the Degradation Product, Ochratoxin α, in the Zebrafish (Danio rerio) Embryo Model of Vertebrate Development.
    Haq M; Gonzalez N; Mintz K; Jaja-Chimedza A; De Jesus CL; Lydon C; Welch A; Berry JP
    Toxins (Basel); 2016 Feb; 8(2):40. PubMed ID: 26861395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The involvement of oxidative stress in ochratoxin A and fumonisin B1 toxicity in rats.
    Domijan AM; Peraica M; Vrdoljak AL; Radić B; Zlender V; Fuchs R
    Mol Nutr Food Res; 2007 Sep; 51(9):1147-51. PubMed ID: 17688296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of mutagenicity of ochratoxin A and B, citrinin, patulin and cnestine in Salmonella typhimurium TA102.
    Würgler FE; Friederich U; Schlatter J
    Mutat Res; 1991 Nov; 261(3):209-16. PubMed ID: 1719413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mycotoxin interactions in poultry and swine.
    Huff WE; Kubena LF; Harvey RB; Doerr JA
    J Anim Sci; 1988 Sep; 66(9):2351-5. PubMed ID: 3170377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dietary exposure to aflatoxin B
    Huong BTM; Tuyen LD; Tuan DH; Brimer L; Dalsgaard A
    Food Chem Toxicol; 2016 Dec; 98(Pt B):127-133. PubMed ID: 27746326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comments on an MNF review about ochratoxin A.
    Degen GH; Gerber MM; Stock S
    Mol Nutr Food Res; 2007 Sep; 51(9):1189; author reply 1190-1. PubMed ID: 17854094
    [No Abstract]   [Full Text] [Related]  

  • 49. Evaluation of two mycotoxin binders to reduce toxicity of broiler diets containing ochratoxin A and T-2 toxin contaminated grain.
    García AR; Avila E; Rosiles R; Petrone VM
    Avian Dis; 2003; 47(3):691-9. PubMed ID: 14562898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of ochratoxin A-induced DNA damage in MDCK cells by alkaline single cell gel electrophoresis (comet assay).
    Lebrun S; Föllmann W
    Arch Toxicol; 2002 Jan; 75(11-12):734-41. PubMed ID: 11876507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of the toxic trigger in mushroom poisoning.
    Matsuura M; Saikawa Y; Inui K; Nakae K; Igarashi M; Hashimoto K; Nakata M
    Nat Chem Biol; 2009 Jul; 5(7):465-7. PubMed ID: 19465932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histopathological studies on the toxicity of ochratoxin A in rats. I. Acute oral toxicity.
    Kanisawa M; Suzuki S; Kozuka Y; Yamazaki M
    Toxicol Appl Pharmacol; 1977 Oct; 42(1):55-64. PubMed ID: 929607
    [No Abstract]   [Full Text] [Related]  

  • 53. The neurotoxic effects of ochratoxin-A are reduced by protein binding but are not affected by l-phenylalanine.
    Bruinink A; Sidler C
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):173-9. PubMed ID: 9344884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of human cytochrome P450-expressing cell lines: application in mutagenicity testing of ochratoxin A.
    de Groene EM; Hassing IG; Blom MJ; Seinen W; Fink-Gremmels J; Horbach GJ
    Cancer Res; 1996 Jan; 56(2):299-304. PubMed ID: 8542584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 1H-2-benzopyran-1-one derivatives, microbial products with pharmacological activity. Relationship between structure and activity in 6-[[1(S)-(3(S),4- dihydro-8-hydroxy-1-oxo-1H-2-benzopyran-3-yl)-3-methylbutyl]-amino]-4(S), 5(S)-dihydroxy-6-oxo-3(S)-ammoniohexanoate.
    Shimojima Y; Hayashi H
    J Med Chem; 1983 Oct; 26(10):1370-4. PubMed ID: 6620300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mycotoxins and health hazards: toxicological aspects and mechanism of action of fumonisins.
    Norred WP; Voss KA; Riley RT; Meredith FI; Bacon CW; Merrill AH
    J Toxicol Sci; 1998 Jul; 23 Suppl 2():160-4. PubMed ID: 9760455
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro investigation of individual and combined cytotoxic effects of ochratoxin A and other selected mycotoxins on renal cells.
    Heussner AH; Dietrich DR; O'Brien E
    Toxicol In Vitro; 2006 Apr; 20(3):332-41. PubMed ID: 16140496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and inhibitory effect on platelet aggregation and antihypertensive activity of 1-hydroxy-2,5-dihydro-1H-imidazole-2-carboxylic acid 3-oxides, 1,3-dihydroxyimidazolidine-2-carboxylic acids, and 1,4-dihydroxy-2,3-piperazinediones.
    Tikhonov YaA ; Mazhukin DG; Grigor'eva LN; Khlestkin VK; Voinova NN; Syropyatov YaB ; Shirinkina SS; Volodarsky LB
    Arch Pharm (Weinheim); 1999 Sep; 332(9):305-8. PubMed ID: 10520299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of 13 C-NMR to the biosynthetic investigations. I. Biosynthesis of ochratoxin A.
    Maebayashi Y; Miyaki K; Yamazaki M
    Chem Pharm Bull (Tokyo); 1972 Oct; 20(10):2172-5. PubMed ID: 4650366
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of some mycotoxins on mitogen-induced blastogenesis and SCE frequency in human lymphocytes.
    Cooray R
    Food Chem Toxicol; 1984 Jul; 22(7):529-34. PubMed ID: 6235161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.